Modified Dynabeads method for enumerating CD4+ T-lymphocyte count for widespread use in resource-limited situations

被引:15
作者
Bi, XQ
Gatanaga, H
Tanaka, M
Honda, M
Ida, S
Kimura, S
Oka, S
机构
[1] Int Med Ctr Japan, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan
[2] Univ Tokyo, Grad Sch Med, Tokyo, Japan
关键词
CD4; monitoring; Dynabeads; resource-limited situations;
D O I
10.1097/00126334-200501010-00001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Dynabeads method showed the potential for enumerating CD4(+) T lymphocytes (CD4 count) in HIV-1-infected individuals. The large volume of Dynabeads required for I sample and complex procedure made the method expensive and not easy for use, howeven To decrease the cost and simplify the procedure, we reduced the volume of the Dynabeads, added wash times, and skipped over the staining step so as to count the CD4 cells directly under an optical microscope. The CD4 count of 246 blood samples using our modified Dynabeads method (DynabeadsCD4) showed a significant correlation with that obtained by flow cytometry (FlowcytoCD4) (r = 0.91 [P < 0.0001]; slope = 1.03, intercept = -16). The sensitivity and specificity for a CD4 count less than 200 cells/muL were 79% and 94%, and for a CD4 count less than 350 cells/muL, the sensitivity and specificity were 95% and 88%, respectively. The positive and negative predictive values for a CD4 count less than 350 cells/muL were 97% and 83%, respectively. The systematic error was 8 cells/muL (95% confidence interval [CI]: 0.4-16). The cost of Dynabeads for 1 sample was less than $1.00; thus, the estimated cost per DynabeadsCD4 test is less than $3.00, including the cost of other disposable materials. Our modified method is simple, economic, and accurate enough to monitor antiretroviral therapy in resource-limited situations.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 16 条
[1]  
[Anonymous], GUID US ANT AG HIV 1
[2]   Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings [J].
Badri, M ;
Wood, R .
AIDS, 2003, 17 (04) :541-545
[3]  
Brando B, 2000, CYTOMETRY, V42, P327, DOI 10.1002/1097-0320(20001215)42:6<327::AID-CYTO1000>3.0.CO
[4]  
2-F
[5]  
BRINCHMANN JE, 1989, J IMMUNOGENET, V16, P177
[6]   A MANUAL BEAD ASSAY FOR THE DETERMINATION OF ABSOLUTE CD4(+) AND CD8(+) LYMPHOCYTE COUNTS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS [J].
CARELLA, AV ;
MOSS, MW ;
PROVOST, V ;
QUINN, TC .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (05) :623-625
[7]   Monitoring of human immunodeficiency virus infection in resource-constrained countries [J].
Crowe, S ;
Turnbull, S ;
Oelrichs, R ;
Dunne, A .
CLINICAL INFECTIOUS DISEASES, 2003, 37 :S25-S35
[8]   Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings:: the ANRS 12-26 study [J].
Diagbouga, S ;
Chazallon, C ;
Kazatchkine, MD ;
de Perre, PV ;
Inwoley, A ;
M'Boup, S ;
David, MP ;
Ténin, AT ;
Soudré, R ;
Aboulker, JP ;
Weiss, L .
AIDS, 2003, 17 (15) :2201-2208
[9]   Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries [J].
Didier, JM ;
Kazatchkine, MD ;
Demouchy, C ;
Moat, C ;
Diagbouga, S ;
Sepulveda, C ;
Di Lonardo, AM ;
Weiss, L .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (02) :193-195
[10]  
GAUDERNACK G, 1989, J IMMUNOGENET, V16, P169